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Introduction
Cardiovascular disease (CVD) has emerged as the leading cause of Maternal 
Mortality in the United States.
CVD accounts for >33% of all pregnancy-related deaths in the United States.
Peripartum Cardiomyopathy (PPCM) affects 1 in 3,000 pregnancies and it accounts 
for 5% of heart transplants in US women. 
Preeclampsia is one of the Hypertensive Disorders of Pregnancy (HDOP) and it has 
been epidemiologically associated with PPCM. 
Epidemiological studies have shown that Preeclampsia is present in 20% of PPCM 
cases.
Maternal Cardiovascular Changes in 
Pregnancy

Hypertensive Disorders 
of Pregnancy
Hypertensive Disorders 
of Pregnancy
Peripartum Cardiomyopathy
PPCM is a dilated cardiomyopathy defined by left ventricular 
dysfunction and development of cardiac failure that presents in late 
pregnancy or early postpartum.
PPCM is a steadily increasing cause of pregnancy-associated morbidity 
and mortality.
The risk factors for PPCM include multiparity, advanced maternal age 
>35years, multiple gestation, African descent, and hypertension. 
Clinical Criteria for Diagnosis of Peripartum
Cardiomyopathy
• Cardiac failure that occurs during last month of pregnancy or first five 
month after delivery.
• Absence of an identifiable cause for cardiac failure
• Absence of pre-existing heart disease
• Echocardiographic criteria showing left ventricular dysfunction:
Ejection Fraction <45% 
(LVEF demonstrates severe left ventricular dysfunction)
Pathophysiology of Peripartum
Cardiomyopathy
PPCM and Preeclampsia are diseases that are both vascular in nature.
It has been suggested that PPCM and Preeclampsia share a common 
pathophysiological mechanism that leads to the clinical manifestation of 
heart failure.
Theories implicated as possible causes or triggering events for PPCM are:
- simply a failed hemodynamic “Stress Test” of pregnancy
- secretion of antiangiogenic factors, the soluble vascular endothelial 
growth factor fms-like tyrosine kinase-1 (sFlt-1)
- Prolactin has vasculotoxic and proinflammatory properties
Pathophysiology of Peripartum
Cardiomyopathy
Pregnancy is characterized by secretion of prolactin by the maternal 
pituitary, and at the same time, the placenta secretes high levels of the 
antiangiogenic molecule sFlt-1.
Interestingly, sFlt-1 serum levels are 10-15 times higher at 4-6 weeks 
postpartum in women who have peripartum cardiomyopathy. 
Case Presentation
A 22 year old primigravida @ 33 weeks and 1 day gestation was a 
transfer of care from an outside hospital.  
• No prenatal care
• Homeless 
• History of depression and substance abuse 
• History of alcohol, tetrahydrocannibol and tobacco use.  
She presented with abdominal pain, shortness of breath, cough, and 
was ill-appearing.  Patient was not aware of her due date as she had no 
ultrasounds done until admission.
Case Presentation
Vitals on presentation: 
Temp 99.2F
Elevated BP 175/99 mmHg
HR 113 
RR 32   
Fetal heart tracing showed a baseline of 145 bpm with minimal 
variability and no accelerations or decelerations.  
The tocodynamometer showed contractions q 3-5 minutes
Case Presentation
Lab results:
Elevated AST/ALT 234/102 units/L 
LDH 903 units/L
Uric Acid 7.0 mg/dl 
WBC 26.2 /L 
BNP 1935 pg/mL
24 hour urine total protein = 4455 mg. 
Case Presentation
Transthoracic echocardiogram revealed LV ejection fraction of 30 to 
35% with global hypokinesis of the LV wall.  
The CXR was consistent with bilateral infiltration and pulmonary 
edema. 
Hospital Course
She was admitted to L & D and given a dose of Betamethasone and 
treated with Ceftriaxone and Azithromycin.  
Cardiology and Social work consults were ordered. 
The Ultrasound evaluation showed cephalic presentation and adequate 
amniotic fluid volume.  Patient was treated with a diuretic Lasix, beta-
blocker Metoprolol, and seizure prophylaxis with Magnesium Sulfate. 
Hospital Course
The clinical diagnosis of Peripartum Cardiomyopathy, Preeclampsia 
with severe features, and Bilateral Pneumonia was made. 
Patient underwent a primary low transverse cesarean delivery for non-
reassuring fetal heart tracing (NRFHT).
A live female infant weighing 1920 grams, 4 pounds 4 ounces, and 
Apgars: 6, 8 was delivered.
Discharge
The patient was discharged home with the usual treatment for PPCM 
of beta-blocker, ACE inhibitor, and calcium channel blocker. 
Her medications were Metoprolol XL 25 mg bid, Lisinopril 10 mg daily, 
Procardia 30 mg daily. 
Lovenox 40 mg daily was given as anticoagulation for VTE prophylaxis  
and Depo-Provera for contraception. 

Clinical Overview
Pre Delivery Post Partum Reference value 
Blood pressure 175/99 mmHg 106/66 mmHg <130/85 mmHg
Pulse Rate 113 bpm 87 bpm 60-100 bpm
Serum K+ 3.3 mEq/L 4.3 mEq/L 3.5 mEq/L
AST 234 units/L 26 units/L 10 – 40 units/L
ALT 102 units/L 34 units/L 7 – 56 units/L
Risk of Recurrence of Peripartum
Cardiomyopathy
Women with a history of peripartum cardiomyopathy remain at high risk for 
recurrence of cardiac dysfunction in subsequent pregnancies, despite 
seemingly full recovery.
It was emphasized to the patient that she would need close follow-up with 
both Cardiology and Obstetric. 
She was informed that she would need a repeat echocardiograms at 3 and 6 
months to assess left ventricular function.
Both the baseline Echo and the 6 month Echo can be used for counselling 
about a subsequent pregnancy ( recurrence, cardiac event, death).

Discussion
In this Appalachian region, there is an increasing occurrence of 
Peripartum Cardiomyopathy presenting concurrently with 
Preeclampsia.
Maternal morbidity and mortality are increased with these two 
combined clinical entities. 
The Appalachian Region
This concurrent clinical presentation of PPCM with associated Preeclampsia 
appears to be an increasing trend in rural Northeast Tennessee. 
The Appalachian region is plagued with economic and psychosocial factors 
that have impacted the health of pregnant women and may have 
contributed to this increase in PPCM.
- Obesity                                  - Smoking
- Physical Inactivity                - Substance Abuse
- Poor Health Literacy            - Poverty 
- Mental Health Disorders
Public Health Perspective
From a Public Health point of view: 
This clinical case highlights the associated psychosocial factors such as 
poverty level, homelessness, substance abuse, maternal mental health 
disorder, and lack of importance of health and wellness that all 
together lead to major clinical disease.

Conclusion
The distinct features of this case are a Caucasian primigravida with a  singleton 
gestation presenting antepartum @ 33weeks with both PPCM and Preeclampsia. 
Healthcare providers should have heightened awareness of this concurrent clinical 
presentation of PPCM and Preeclampsia, especially in the postpartum period.
There is a significant overlap between signs and symptoms of cardiac disease and 
those of normal pregnancy.
Healthcare providers must familiarize themselves with risk factors, warning 
signs/symptoms, and physical examination findings that are suggestive of an 
underlying cardiac condition to ensure prompt diagnosis and treatment.
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